Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Folge dem Geld: Methan im Fokus der COP31!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
IM

WKN: A2AG0F | ISIN: SE0006091997 | Ticker: 1YR
Frankfurt
18.11.26 | 20:15
0,000 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
IMMUNOVIA AB Chart 1 Jahr
5-Tage-Chart
IMMUNOVIA AB 5-Tage-Chart

Aktuelle News zur IMMUNOVIA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
06.11.Listing Of Units Rights And Paid Subscription Units Of Immunovia AB320With effect from November 09, 2026, the units rights of Immunovia AB will be traded on the list for Equity rights. Trading will continue up until and including November 18, 2026. ...
► Artikel lesen
04.11.Immunovia AB: Immunovia publishes prospectus in connection with rights issue147NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA...
► Artikel lesen
03.11.Immunovia AB (publ) receives observation status236On November 2, 2026, Immunovia AB (publ) (the "Company") disclosed its interim report for the third quarter of 2026 with information on the Company's financial situation. According to item 4.1.1...
► Artikel lesen
03.11.XFRA CAPITAL ADJUSTMENT INFORMATION - 03.11.2026338Das Instrument IR0 IT0005528069 REWAY GROUP S.P.A. EQUITY wird cum Kapitalmassnahme gehandelt am 03.11.2026 und ex Kapitalmassnahme am 04.11.2026 The instrument IR0 IT0005528069 REWAY GROUP S.P.A. EQUITY...
► Artikel lesen
IMMUNOVIA Aktie jetzt für 0€ handeln
02.11.Earnings Call: Immunovia übertrifft Umsatzerwartungen in Q3 2026 - Aktie legt vorbörslich zu3
02.11.Immunovia-Aktie springt zweistellig an: Kommerzialisierung nimmt deutlich an Fahrt auf7
02.11.Immunovia AB Q3 Loss Decreases5
02.11.Immunovia AB: Immunovia Publishes Interim Report for July-September 2026185Highlights July-September 2026Net sales and operating results for Q3 2026 in line with expectations: Net sales for the period amounted to 843 KSEK (101), comprising revenue from PancreaSure test sales...
► Artikel lesen
29.10.Immunovia AB: Bulletin from the extraordinary general meeting in Immunovia AB (publ)212Today, on 29 October 2026, an extraordinary general meeting was held in Immunovia AB (publ). A summary of the adopted resolutions follows below. Resolution on amendment of the Articles of AssociationThe...
► Artikel lesen
28.10.Immunovia AB: Immunovia announces final terms of rights issue183NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA...
► Artikel lesen
28.09.Immunovia AB: Immunovia carries out a rights issue of units of approximately SEK 63 million248NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA...
► Artikel lesen
06.08.Immunovia AB Q2 Loss Narrows1
06.08.Immunovia AB: Immunovia Publishes Interim Report for April-June 2026289Highlights April-June 2026Net sales and operating results for Q2 2026 in line with expectations: Net sales of 381 KSEK (90) for the period were comprised primarily of revenue from PancreaSure tests...
► Artikel lesen
13.05.Immunovia AB: Bulletin From The Annual General Meeting On 13 May 2026 In Immunovia AB (publ)352Today, on 13 May 2026, the annual general meeting of Immunovia AB (publ) was held. A summary of the adopted resolutions follows below. Resolution on the adoption of the accounts and allocation of resultThe...
► Artikel lesen
07.05.Immunovia AB: Immunovia Publishes Interim Report for January-March 2026458Highlights January-March 2026Net sales and operating results for Q1 2026 in line with expectations: Net sales of 374 KSEK (139) for the period included royalties and revenues from PancreaSure tests....
► Artikel lesen
24.02.Immunovia AB: Immunovia Publishes Full Year Report for 2025769Highlights October-December 2025Net sales and operating results for Q4 2025 in line with expectations: Net sales of 354 KSEK for the period (455) largely reflected royalty revenue. Operating loss was...
► Artikel lesen
20.01.Immunovia AB: The Board of Directors of Immunovia withdraws proposal for reverse share split and cancels Extraordinary General Meeting273Following discussions with major shareholders, the Board of Directors of Immunovia AB (publ) ("Immunovia" or the "Company") has decided to withdraw the proposal for a reverse share split and the Extraordinary...
► Artikel lesen
19.01.Immunovia AB: Immunovia receives state regulatory approval for PancreaSure in California and initiates commercial rollout397Immunovia AB (IMMNOV: Nasdaq Stockholm), a pancreatic cancer diagnostics company, today announced that it has received regulatory approval for its PancreaSure test in California, US, enabling commercial...
► Artikel lesen
17.12.25Immunovia AB: The Board of Directors of Immunovia proposes a reverse share split953The Board of Directors of Immunovia AB (publ) ("Immunovia" or the "Company") proposes that an Extraordinary General Meeting on 22 January 2026 resolves to carry out a reverse share split, in the ratio...
► Artikel lesen
26.11.25Immunovia AB: Immunovia receives final Medicare payment rate for PancreaSure test524LUND, Sweden - Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announced that the Centers for Medicare & Medicaid Services (CMS) has finalized a national payment...
► Artikel lesen
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1